S127 Pill — YELLOW OVAL, 19mm — Folic Acid

No photo available

Imprint	S127
Colour	YELLOW
Shape	OVAL
Size	19
Strength	BETA CAROTENE 3000 [iU];ASCORBIC ACID 120 mg;CHOLECALCIFEROL 800 [iU];.ALPHA.-TOCOPHEROL ACETATE, DL- 3 mg;THIAMINE MONONITRATE 1.8 mg;RIBOFLAVIN 4 mg;NIACINAMIDE 20 mg;PYRIDOXINE HYDROCHLORIDE 50 mg;CYANOCOBALAMIN 12 ug;CALCIUM CARBONATE 230 mg;IRON 27 mg;MAGNESIUM OXIDE 25 mg;ZINC OXIDE 25 mg;CUPRIC OXIDE 2 mg;IODINE 220 ug;FOLIC ACID 1 mg
Dosage form	Tablet
Manufacturer	Seton Pharmaceuticals
NDC	13925-127
Schedule	—
Availability	—
Ingredients	BETA CAROTENE[BETA CAROTENE];ASCORBIC ACID[ASCORBIC ACID];CHOLECALCIFEROL[CHOLECALCIFEROL];.ALPHA.-TOCOPHEROL ACETATE, DL-[ALPHA-TOCOPHEROL];THIAMINE MONONITRATE[THIAMINE];RIBOFLAVIN[RIBOFLAVIN];NIACINAMIDE[NIACINAMIDE];PYRIDOXINE HYDROCHLORIDE[PYRIDOXINE];CYANOCOBALAMIN[CYANOCOBALAMIN];CALCIUM CARBONATE[CALCIUM];IRON[IRON];MAGNESIUM OXIDE[MAGNESIUM];ZINC OXIDE[ZINC];CUPRIC OXIDE[COPPER];IODINE[IODINE];FOLIC ACID[FOLIC ACID]

What does this imprint mean?

The imprint "S127" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Folic Acid

Uses and warnings

No boxed warning. Key warning: "administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient" - doses above 0.1 mg daily may correct the blood picture while neurologic damage from B12 deficiency continues to progress, so B12 deficiency must be excluded before treating with folic acid alone. The label also notes folic acid may antagonize phenytoin's anticonvulsant action.

Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.

Read the full drug profile →